CRDF 8-K 2026-09-14

Cardiff Oncology, Inc. (CRDF) 8-K dated 2026-09-14 — accession 0001493152-26-042506. This URL is the filing, not the CRDF hub.

Cardiff Oncology, Inc. (CRDF) is a biotechnology company listed on US.

Cardiff Oncology, Inc. filed a 8-K on 2026-09-14. Accession 0001493152-26-042506.

Cached items: 1.01, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CRDF revenue for 2025-12-31 was $593.0K. Net income was -$45.9M. Revenue was down 13.2% from 2024-12-31 to 2025-12-31. CRDF currently screens at market cap $238.8M.

Not investment advice. The CRDF SEC hub lists recent forms. The stock page is the research view.